Literature DB >> 33767700

PD-1 Blockade Modulates Functional Activities of Exhausted-Like T Cell in Patients With Cutaneous Leishmaniasis.

Renan Garcia de Moura1, Luciana Polaco Covre1,2, Carlos Henrique Fantecelle1, Vitor Alejandro Torres Gajardo1, Carla Baroni Cunha1, Lorenzzo Lyrio Stringari1, Ashton Trey Belew3,4, Camila Batista Daniel5, Sandra Ventorin Von Zeidler5, Carlos Eduardo Tadokoro6, Herbert Leonel de Matos Guedes7,8, Raphael Lubiana Zanotti9, David Mosser3, Aloisio Falqueto10, Arne N Akbar2, Daniel Claudio Oliveira Gomes1,5.   

Abstract

Patients infected by Leishmania braziliensis develop debilitating skin lesions. The role of inhibitory checkpoint receptors (ICRs) that induce T cell exhaustion during this disease is not known. Transcriptional profiling identified increased expression of ICRs including PD-1, PDL-1, PDL-2, TIM-3, and CTLA-4 in skin lesions of patients that was confirmed by immunohistology where there was increased expression of PD-1, TIM-3, and CTLA-4 in both CD4+ and CD8+ T cell subsets. Moreover, PDL-1/PDL-2 ligands were increased on skin macrophages compared to healthy controls. The proportions PD1+, but not TIM-3 or CTLA-4 expressing T cells in the circulation were positively correlated with those in the lesions of the same patients, suggesting that PD-1 may regulate T cell function equally in both compartments. Blocking PD-1 signaling in circulating T cells enhanced their proliferative capacity and IFN-γ production, but not TNF-α secretion in response to L. braziliensis recall antigen challenge in vitro. While we previously showed a significant correlation between the accumulation of senescent CD8+CD45RA+CD27- T cells in the circulation and skin lesion size in the patients, there was no such correlation between the extent of PD-1 expression by circulating on T cells and the magnitude of skin lesions suggesting that exhausted-like T cells may not contribute to the cutaneous immunopathology. Nevertheless, we identified exhausted-like T cells in both skin lesions and in the blood. Targeting this population by PD-1 blockade may improve T cell function and thus accelerate parasite clearance that would reduce the cutaneous pathology in cutaneous leishmaniasis.
Copyright © 2021 Garcia de Moura, Covre, Fantecelle, Gajardo, Cunha, Stringari, Belew, Daniel, Zeidler, Tadokoro, de Matos Guedes, Zanotti, Mosser, Falqueto, Akbar and Gomes.

Entities:  

Keywords:  Leishmania braziliensis; PD-1; T cell exhaustion; cutaneous leishmaniasis; immunosenescence; inhibitory checkpoint receptors; senescent T cells

Year:  2021        PMID: 33767700      PMCID: PMC7985249          DOI: 10.3389/fimmu.2021.632667

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  40 in total

1.  CD8 T cell exhaustion in human visceral leishmaniasis.

Authors:  Shalini Gautam; Rajiv Kumar; Neetu Singh; Abhishek Kumar Singh; Madhukar Rai; David Sacks; Shyam Sundar; Susanne Nylén
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

Review 2.  T-cell exhaustion: characteristics, causes and conversion.

Authors:  John S Yi; Maureen A Cox; Allan J Zajac
Journal:  Immunology       Date:  2010-02-23       Impact factor: 7.397

3.  Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.

Authors:  Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

Review 4.  Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells.

Authors:  Ben Youngblood; E John Wherry; Rafi Ahmed
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

5.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 6.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

7.  Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways.

Authors:  Sian M Henson; Richard Macaulay; Natalie E Riddell; Craig J Nunn; Arne N Akbar
Journal:  Eur J Immunol       Date:  2015-03-30       Impact factor: 5.532

8.  Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis.

Authors:  Adriana Egui; Darién Ledesma; Elena Pérez-Antón; Andrés Montoya; Inmaculada Gómez; Sara María Robledo; Juan José Infante; Ivan Darío Vélez; Manuel C López; M Carmen Thomas
Journal:  Front Cell Infect Microbiol       Date:  2018-11-19       Impact factor: 5.293

9.  PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals.

Authors:  Rémi Fromentin; Sandrina DaFonseca; Cecilia T Costiniuk; Mohamed El-Far; Francesco Andrea Procopio; Frederick M Hecht; Rebecca Hoh; Steven G Deeks; Daria J Hazuda; Sharon R Lewin; Jean-Pierre Routy; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  Nat Commun       Date:  2019-02-18       Impact factor: 14.919

10.  PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis.

Authors:  Daniel Holanda Barroso; Sarah De Athayde Couto Falcão; Jorgeth de Oliveira Carneiro da Motta; Laís Sevilha Dos Santos; Gustavo Henrique Soares Takano; Ciro Martins Gomes; Cecília Beatriz Fiuza Favali; Beatriz Dolabela de Lima; Raimunda Nonata Ribeiro Sampaio
Journal:  Front Immunol       Date:  2018-05-11       Impact factor: 7.561

View more
  5 in total

1.  Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology.

Authors:  Carlos Henrique Fantecelle; Luciana Polaco Covre; Renan Garcia de Moura; Herbert Leonel de Matos Guedes; Camila Farias Amorim; Phillip Scott; David Mosser; Aloisio Falqueto; Arne N Akbar; Daniel Claudio Oliveira Gomes
Journal:  Immunology       Date:  2021-09-01       Impact factor: 7.397

2.  Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation.

Authors:  Yegnasew Takele; Emebet Adem; Susanne Ursula Franssen; Rebecca Womersley; Myrsini Kaforou; Michael Levin; Ingrid Müller; James Anthony Cotton; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2022-06-24

3.  Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function.

Authors:  Yu Ping; Jiqi Shan; Yaqing Liu; Fengsen Liu; Liuya Wang; Zhangnan Liu; Jieyao Li; Dongli Yue; Liping Wang; Xinfeng Chen; Yi Zhang
Journal:  Cancer Immunol Immunother       Date:  2022-10-20       Impact factor: 6.630

Review 4.  T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis.

Authors:  Juliana C Costa-Madeira; Gabrielly B Trindade; Paulo H P Almeida; João S Silva; Vanessa Carregaro
Journal:  Front Immunol       Date:  2022-05-02       Impact factor: 8.786

Review 5.  Host-Directed Therapies for Cutaneous Leishmaniasis.

Authors:  Fernanda O Novais; Camila Farias Amorim; Phillip Scott
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.